Clinical Trial Update: An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis [Phase 4]

View source ↗

Summary

Open-label, single-arm Phase 4 trial of vedolizumab in newly diagnosed active ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: University of Pennsylvania | Conditions: Ulcerative Colitis | Phase 4 | Status: WITHDRAWN